Ask AI
IL-13 Mapping and Atopic Dermatitis Manifestations
Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Released: June 23, 2025

Expiration: June 22, 2026

Activity

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

  • Contributors to epidermal barrier dysfunction (eg, environmental triggers)
  • IL-13 as a key cytokine in AD pathogenesis
  • Targeted AD therapies that inhibit IL-13
  • A detailed patient case to highlight take-home points